WUHAN HEALTHGEN BIOTECHNOLOGY CORP(SSE:688765)

Wuhan Healthgen Biotechnology Corp. engages in the research, development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients and Recombinant Human Epidermal Growth Factor, Recombinant Human Basic Fibroblast Growth Factor, Recombinant Human Insulin-like Growth Factor, Recombinant Human Vascular Endothelial Growth Factor and Recombinant Human Keratinocyte Growth Factor. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.